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The SARS-CoV-2 pandemic has over 1 million cases
with more than 50 000 deaths globally to date (early
April 2020)1. Disease spread in Italy has been rapid, with
in excess of 115 000 SARS-CoV-2-positive patients and
13 000 deaths (1 April 2020). Mortality is currently 5⋅2
per cent in Tuscany, compared with 11 per cent nation-
wide. Healthcare systems have been forced to reorganize
surgical activities2 as they struggle with an overwhelm-
ing number of critically ill patients. One of the lessons
we learnt from the 2003 SARS outbreak is that case
identification was limited by non-specific mild symptoms,
with a flu-like prodrome progressing to fulminant disease,
which could quickly overwhelm hospitals3 without plans
for surge capacity, patient transfer, or sufficient numbers of
trained staff. In addition to this, initial delays in transposing
regional indications to stop surgical activities and to imple-
ment proper infection control procedures contributed to a
disproportionate number of healthcare workers becoming
infected (approximately 9000 in Italy alone by 30 March
2020).
The organizational model adopted was based on a rapid
response to early signs of incoming crisis, and elective
surgical activity (including outpatient consultations) was
reduced to a minimum. Hospital areas capable of inten-
sive care unit (ICU) level monitoring, including the post
anaesthesia care unit or operating room, were repurposed
as temporary ICU facilities. On 6 March the regional gov-
ernment defined three types of hospitals. Type A univer-
sity hospitals are focused mainly on SARS-CoV-2 patient
care, whereas type B hub-hospitals have ICU resources
and the ability to organize two different pathways for
SARS-Cov-2-positive and -negative patients; in both type
A and B hospitals, scheduled elective surgery and outpa-
tient activities are suspended, while emergency and urgent
surgery, cancer treatments, transplants and burn care cen-
tres are running normally. Any admitted patient must be
tested for SARS-CoV-2. Type C spoke hospitals with lim-
ited or no ICU beds, including private hospitals, are dedi-
cated to non-SARS-CoV-2 patients.
Infected patients admitted via the emergency room
should be quarantined (both spatially and in staff resources)
according to the local infectious diseases policy. To
decrease the risk of in-hospital transmission, patients with
SARS-CoV-2 should separated from others, ideally in
single rooms, and staff should consider wearing surgical or
N95 masks, a disposable cap to cover the hair, and gloves4.
Medical personnel should use fast-drying hand antisep-
tics and change gloves immediately after contact with a
patient, body fluids or contaminated material5. Elective
surgical activity is reduced to a minimum so operating
rooms can be converted into ICUs using post anaesthesia
care unit beds first, leaving space for emergency/urgent
surgery. Admissions should follow two different pathways:
one for SARS-CoV-2-positive and the other for -negative
patients. To decrease the risk of in-hospital transmission
hospitals should separate staff caring for patients with
SARS-CoV-2 from others. All SARS-CoV-2-negative
patients should also have the shortest possible hospital stay
and be cared for in a designated ‘infection-free’ area or
spoke (non-SARS-CoV-2) hospital.
High-intensity, pressured work will lead to staff fatigue
and even psychological crises so staff need psychological
support, reasonable scheduling, and appropriate rest.
First-line medical staff should try to identify their negative
psychological emotions, enable positive self-counselling,
and seek professional help when needed6. Symptoms
and/or fever should stimulate testing for the virus expedi-
ently. Ideally, there should be routine testing of healthcare
© 2020 BJS Society Ltd BJS
Published by John Wiley & Sons Ltd
F. Di Marzo, M. Sartelli, R. Cennamo, G. Toccafondi, F. Coccolini, G. La Torre et al.
staff, serological confirmation immunity, and vaccination
of those without natural immune responses.
The numbers of emergency admissions with coexistent
viral infection are increasing, adding to the pressure on
resources. Experienced surgeons should assess patients
before admission to reduce unnecessary admissions by 20
to 30 per cent, with substantial resource savings7. Effective
communication should ensure closed-loop information
transfer on any patient’s SARS-CoV-2 status. Transanal
procedures, stomas for faecal diversion, and intestinal anas-
tomoses may risk aerosol contamination8. Laparoscopy is
an option but the relative risk of viral exposure versus open
procedures remains unclear and in critically ill patients with
lung dysfunction, sepsis or shock, open surgery is advised.
An operating room maintained at negative pressure with a
high frequency air exchanges (at least 25 cycles/h) or des-
ignated ‘contaminated’ surgery-only is sensible9.
Surgical patients who are suspected of being or who test
positive for SARS-CoV-2 infections should follow the local
management protocol, which may include: wearing spec-
ified bracelets and surgical masks, having their medical
records marked with warning labels, and being brought
through defined routes and lifts to the special isolation
area for recovery. A dedicated portable ventilator should
be used when managing infected ICU patients, switching
off the gas flow and closing the endotracheal tube to reduce
aerosol production when connecting to the operating room
ventilator10. The gas sampling tube should be protected
by a high-efficiency particulate air (HEPA) filter and the
soda lime should be changed regularly10. Anaesthetists
should use three-level protective measures with HEPA fil-
ters on both limbs of the circuit and consider disposable
components9. For surgical cases in infected patients, all
staff should take a training course on personal protective
equipment use: disposable double-layer hats, N95 masks,
surgical gowns for single use or medical protective cloth-
ing, goggles, or full face mask, and double-layer sterile
gloves. According to the Association for the Advancement
ofMedical Instrumentation (AAMI), the protection level of
the surgical gowns depends on the type of procedure. Level
4 is the highest fluid and microbial barrier, and is needed
for long, fluid-intensive procedures; level 3 is indicated as
a moderate fluid barrier protection11.
The Chinese New Coronavirus Infected Pneumonia
Diagnosis and Treatment Plan (Trial Version 7) high-
lighted the following criteria for considering removing
quarantine and transferring the patient to a general
ward12: a normal body temperature for more than 3 days;
respiratory symptoms significantly relieved; lung imaging
showing that the inflammation has been significantly
absorbed; and a negative SARS-CoV-2 nucleic acid
amplification test (sampling interval at least 24 h) for
specialist treatment or discharge based on their condition.
The Italian Ministero della salute – Consiglio Superiore
di Sanità stated on 28 February 2020 that SARS-CoV-2
patients can be considered cured if the symptoms resolve
and two tests for SARS-CoV-2 at 24-h intervals are nega-
tive. For patients who clinically recover earlier than 7 days
after onset, an interval of 7 days should elapse between the
first and the final test. Virus clearance is defined as viral
RNA disappearance from bodily fluids accompanied by
the appearance of specific IgG.
The Singapore National Centre for Infectious Diseases
(NCID) released the following guidelines on de isola-
tion of SARS-CoV-2 suspected cases13: discharge patient
with advisory and clinical follow-up if indicated and with
daily calls until day 14 after the last possible exposure,
under the following conditions: patient afebrile for at
least 24 h, two respiratory samples tested negative for
SARS-CoV-2 by polymerase chain reaction (PCR) in at
least 24 h, day of illness from onset at least 6 days, or
alternative aetiology found (for example, influenza, bac-
teraemia), or no close contact with a SARS-CoV-2 case,
or no in-patient care required for other reasons. The US
Centre for Disease Control released interim guidance for
discontinuation of transmission-based precautions and dis-
position of hospitalized patients with SARS-CoV-214: neg-
ative real-time PCR results from at least two consecutive
sets of nasopharyngeal and throat swabs collected at least
24 h apart from a patient with SARS-CoV-2 (a total of
four negative specimens) and resolution of fever, without
antipyretic medications, improvement in illness signs and
symptoms.
Regarding possible antiviral therapy, the Italian Society
for Infectious and Tropical Disease released guidelines on
13 March 2020. The cut-off is the condition of the res-
piratory system evaluated using the Brescia Covid Res-
piratory severity scale: in patients before intubation the
disease is primarily controlled by anti-inflammatory treat-
ment (tocilizumab) in association with early antiviral and
antiretroviral therapy. In mechanically ventilated patients
the strategy is based on high-pressure ventilation and prone
positioning. There is no evidence of efficacy of prophylac-
tic chloroquine or hydroxychloroquine and the use is not
recommended. Remdesvir has been shown to be active in
preclinical studies on SARS-CoV and MERS-CoV infec-
tions by acting on the viral polymerase of coronavirus.
The drug is not registered in Italy, and can be used only
for ‘compassionate’ reasons, subject to approval by an
Ethics Committee. There are multiple clinical trials ongo-
ing and it is expected that a vaccine will be available within
months.
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The BJS team wish to reach out to express our support and gratitude to surgeons and healthcare workers around
the globe.These are difficult times and your leadership is key to providing the best care possible.BJS welcomes
submissions relating to the challenges faced in this pandemic (expect publication within a week). A blog has been
launched (cuttingedgeblog.com) and publication of accepted pieces will be within hours.
Best wishes to you all.
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